adrenergic beta-3 receptor agonists

Preferred Label : adrenergic beta-3 receptor agonists;

MeSH definition : Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS.;

MeSH synonym : adrenergic beta-3 receptor agonist; adrenergic beta 3 receptor agonist; adrenergic beta-3 agonists; adrenergic beta 3 agonists; agonists, adrenergic beta-3; beta-3 agonists, adrenergic; adrenergic beta 3 receptor agonists; Adrenergic beta3-Agonists; Adrenergic beta3 Agonists; beta3-Agonists, Adrenergic;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D058667;

UMLS CUI

C2936485;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Beta-3 adrenergic receptor agonist (disposition) [SNOMED CT concept]
Indexing information
- 2-(cyclohexyloxy)-4-(4-(2-((2-hydroxy-2-(4-methoxyphenyl)ethyl)amino)ethyl)phenyl)-N-methanesulfonybenzamide [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, adrenergic, beta-3 [MeSH Descriptor]
Record concept(s)
- adrenergic beta-3 receptor agonists [MeSH concept]
See also (suggested by CISMeF)
- receptors, adrenergic, beta-3 [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-(2-chloro-4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)phenoxy)acetic acid [MeSH Supplementary Concept]
- 4'-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)-3-methoxybiphenyl-4-carboxylic acid [MeSH Supplementary Concept]
- 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(2-pyridyl)acetanilide [MeSH Supplementary Concept]
- 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(pyrazin-2-yl)acetanilide [MeSH Supplementary Concept]
- 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(pyrimidin-2-yl)acetanilide [MeSH Supplementary Concept]
- Amibegron hydrochloride [MeSH Supplementary Concept]
- N-((3-((2-((2-hydroxy-2-(3-chlorophenyl)ethyl)amino)propyl)amino)phenyl)acetyl)-4-methylbenzenesulfonamide [MeSH Supplementary Concept]
- N-((4-((2-((2-hydroxy-2-(3-chlorophenyl)ethyl)amino)propyl)amino)phenyl)acetyl)-4-methylbenzenesulfonamide [MeSH Supplementary Concept]
- N-(4-(2-((2-hydroxy-2-(3-pyridinyl)ethyl)amino)ethyl)phenyl)-4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenesulfonamide [MeSH Supplementary Concept]
- disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate [MeSH Supplementary Concept]
- ethyl 2-(2-chloro-4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)phenoxy)acetate [MeSH Supplementary Concept]
- ethyl 4-(4-((2-hydroxy-3-(4-hydroxy-3-((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoate [MeSH Supplementary Concept]
- mirabegron [MeSH Supplementary Concept]
- ritobegron [MeSH Supplementary Concept]
- solabegron [MeSH Supplementary Concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients